TRACON Pharmaceuticals Inc (NAS:TCON)
$ 1.49 -0.03 (-1.97%) Market Cap: 3.99 Mil Enterprise Value: -4.34 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 29/100

TRACON Pharmaceuticals Inc at HC Wainwright Investment Conference - New York Transcript

Sep 11, 2023 / 11:00AM GMT
Release Date Price: $4.4 (-6.10%)
Zachary Berman
H. C. Wainwright & Co., LLC - Analyst

Good afternoon, everyone, and thank you for joining the H.C. Wainwright 25th Annual Global Investment Conference on September 11 to the 13, 2023. My name is Zachary Berman, and I'm an investment banking analyst at H.C. Wainwright. We're confident we are going to be able to provide value to you, with over 650 companies presenting at this conference, in multiple sector tracks devoted to life sciences, cryptocurrency, blockchain and fintech, technology, media and telecommunications, clean tech, metals and mining, and growth.

H.C. Wainwright is a full-service investment bank, dedicated to providing corporate finance, strategic advisory, and related services to public and private companies across multiple sectors and regions. We have a total of 25 publishing senior analysts and over 622 companies covered across all sectors. Please visit hcw.co.com for more information. But that said, have a productive and enjoyable day, and I'd like to introduce the presenter. I'd like to welcome Charles Theuer, who is the Chief Executive Officer of TRACON

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot